Monitoring Continuum ISSUE-3 Atrial Fibrillation Classification.

Slides:



Advertisements
Similar presentations
Widimsky P, Tousek P, Rokyta R, et al. Charles University Prague, CZ PRAGUE-7 Study (Hot Lines presenter)
Advertisements

Atrial Fibrillation in Patients with Cryptogenic Stroke Gladstone DJ et al. N Engl J Med 2014; 370: Presented by Kris Huston | July 21, 2014.
Atrial Fibrillation Project, SSNAP July to September 2013 and QOF Indicators 2012/2013 Surrey Downs CCG.
Automatic Analysis of ECG Signals Recorded with the wireless DELTA ePatch Technology Dorthe Bodholt Nielsen, Hospital Healthcare facility.
Stoke On Trent CCG – Atrial Fibrillation Service AF Nurse in GP Practice Interfacing Primary and Secondary Care for AF Stroke Prevention Jodie Williams.
THE HEART’S ELECTRICAL SYSTEM Marco Perez, MD Center for Inherited Cardiovascular Disease Inherited Cardiac Arrhythmia Clinic June 20, 2013.
R2. 최태웅 / Pf. 김진배. BACKGROUND  Ischemic stroke : leading causes of death and disability : cause remains unexplained after routine evaluation → Cryptogenic.
From: Incidence, Predictive Factors, and Prognostic Value of New-Onset Atrial Fibrillation Following Transcatheter Aortic Valve Implantation J Am Coll.
Cryptogenic Stroke and AF
An approach to using risk scores for stroke and bleeding in clinical practice. An approach to using risk scores for stroke and bleeding in clinical practice.
Addressing the Challenges in Primary and Secondary Stroke Prevention
Covering the Bases in Cardioversion
Silent No More:.
Burden of Atrial Fibrillation The Percentage of Strokes Attributable to AF Increases With Age.
Anticoagulant Safety Remains a Problem Emergency Hospitalizations for Adverse Drug Events.
NOACs for Cancer-Associated Thrombosis:
Atrial Fibrillation & Stroke Prevention in the West Midlands
Atrial Fibrillation and PCI
Anticoagulants in Interventional Cardiology:
Setareh Omran, MD Vascular Neurology Fellow
Updates in Anticoagulation: What Did We Learn From ESC 2017?
Barriers to Oral Anticoagulant Use for Stroke Prevention in AF
The ABCs of AF.
Access to NOAC Therapy:
Overall burden of AF associated with higher risk of thromboembolism and ischemic stroke An analysis of the KP-RHYTHM study, in patients with paroxysmal.
Appropriate Stroke Prevention Strategies in Atrial Fibrillation
Patient Presentation Patient’s Changing Condition Multiple Considerations To Balance.
Oral Anticoagulants in AFa,b A Brief History.
Selecting NOACs for High-Risk Patients
Abbreviated Protocols for Breast Cancer Screening
A Call to Action on Cryptogenic Stroke
Revealing Characteristics of Patients at High Risk for Developing Atrial Fibrillation.
Decision-making in the eRA of Treating to Target
Stroke and AF.
Assessing the Risk for Stroke in Patients With Atrial Fibrillation
Volume 13, Issue 7, Pages (July 2016)
Applying Real-World Evidence in Atrial Fibrillation Into Clinical Care:
Case Collection in RA: Highlights of an Interactive Workshop
WHO Clinical Classification of PH Complex Cases in PH.
Access to NOAC Therapy:
What Anticoagulant Registries Are Revealing
Nat. Rev. Cardiol. doi: /nrcardio
Cardiac Issues: Atrial fibrillation, Pacemakers, Stents, and Rehab
Volume 13, Issue 8, Pages (August 2016)
The New Landscape of ABSSTI Treatment Opportunities to Improve Patient Care.
Atrial Fibrillation.
Updated Guideline Recommendations for the Definitive Diagnosis of Unexplained Syncope.
Taking the "Cryptogenic" Out of Cryptogenic Stroke
Identifying High-Risk AF Patients
Study Background and Rationale Updated October 24, 2018
When Is Intrathecal Drug Delivery Appropriate?
Long-term detection of atrial fibrillation with insertable cardiac monitors in a real-world cryptogenic stroke population  Paul D. Ziegler, John D. Rogers,
Improving Outcomes in AF: Do the NOACs Hold Their Promise In The Real World?
Updates in Anticoagulation: Key Sessions at ESC 2017
-.&- ·Af& Q 0 "i'/
The ABCs of AF.
Taking the "Cryptogenic" Out of Cryptogenic Stroke
5 Good Minutes on Atrial Fibrillation-related Stroke
What is “AF Burden”?. What is “AF Burden”? AF Burden and Stroke Risk ASSERT Study.
When Is Intrathecal Drug Delivery Appropriate?
The American Journal of Medicine
Nat. Rev. Cardiol. doi: /nrcardio
Evaluating the Science of Cardiogenic Shock
Real-World Data in Cardiology: Focus on Atrial Fibrillation
Overall burden of AF associated with higher risk of thromboembolism and ischemic stroke An analysis of the KP-RHYTHM study, in patients with paroxysmal.
Figure 1 Novel markers of increased stroke risk in AF
Top Tips in Evidence-Based Care for HFrEF
Extraordinary Cases in Stroke Prevention
The Power of As-Treated Analyses
Treating Pulmonary Embolism Today
Presentation transcript:

Monitoring Continuum

ISSUE-3

Atrial Fibrillation Classification

Cryptogenic Stroke and Atrial Fibrillation

AF Management Guidelines Considerations for Anticoagulant Selection

SURPRISE TRIAL

Time from Cryptogenic Stroke to AF Detection by ICM Results from SURPRISE study

CRYSTAL AF

Atrial Fibrillation Duration in ICM Arm at 12 Months (N = 29)

Feedback Loop for Care Team

Clinical Scenario Presentation and Work-up

Evaluation for Cryptogenic Stroke

Clinical Scenario Continuous Monitoring

Current and Emerging Indications for Implantable Cardiac Monitoring

AF Burden During Blanking Period Predicts Response to RFA at 12 Months

DISCERN AF Prospective Multicenter Study

Abbreviations

Abbreviations (cont)

References

References (cont)

References (cont)

References (cont)

References (cont)

References (cont)

References (cont)

References (cont)